Related references
Note: Only part of the references are listed.Prophylactic cranial irradiation in extensive small-cell lung cancer
Ben Slotman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Assessment of epidermal growth factor receptor (EGFR, ErbB1) and HER2 (ErbB2) protein expression levels and response to lapatinib (Tykerb®, GW572016) in an expanded panel of human normal and tumour cell lines
D. W. Rusnak et al.
CELL PROLIFERATION (2007)
Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer
Jochen Gaedcke et al.
MODERN PATHOLOGY (2007)
Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain
Diane Palmieri et al.
CANCER RESEARCH (2007)
Lapatinib plus capecitabine for HER2-positive advanced breast cancer
Charles E. Geyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer
Zsolt Gabos et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Primary breast cancer phenotypes associated with propensity for central nervous system metastases
Yee-Lu Tham et al.
CANCER (2006)
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
BC Pestalozzi et al.
ANNALS OF ONCOLOGY (2006)
Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: Implications for progression of ErbB2-overexpressing tumors
Lixing Zhan et al.
CANCER RESEARCH (2006)
Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells
GE Konecny et al.
CANCER RESEARCH (2006)
Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma in situ of the breast in a human xenograft model and on breast and ovarian cancer cell growth in vitro and in vivo
F Warnberg et al.
BREAST CANCER RESEARCH (2006)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Breast cancer metastasis to the central nervous system
RJ Weil et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas
HA Burris et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy
M Ryberg et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
ERBB receptors and cancer: The complexity of targeted inhibitors
NE Hynes et al.
NATURE REVIEWS CANCER (2005)
Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients
MP DiGiovanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment
E Shmueli et al.
EUROPEAN JOURNAL OF CANCER (2004)
Brain Metastases from breast cancer: Identification of a high-risk group
AJ Evans et al.
CLINICAL ONCOLOGY (2004)
Central nervous system metastases in women after multimodality therapy for high risk breast cancer
LA Carey et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Risk factors for brain relapse in patients with metastatic breast cancer
K Slimane et al.
ANNALS OF ONCOLOGY (2004)
Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling
YM Agazie et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival
KD Miller et al.
ANNALS OF ONCOLOGY (2003)
Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma
JC Bendell et al.
CANCER (2003)
The rationale for adjuvant whole brain radiation therapy with radiosurgery in the treatment of single brain metastases
RA Patchell et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2003)
A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro
T Yoneda et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)